Guilin Sanjin announced that recently, the wholly-owned subsidiary Baochuan Biotech and Baifan Biotech applied to the Shanghai branch of Xiamen International Bank for an increase of 20 million yuan and 40 million yuan in credit lines, respectively, and the company provided guarantees for them. Before this guarantee, the company's guarantee balances for Baochuan Biotech and Baifan Biotech were 85 million yuan and 20 million yuan respectively; after this guarantee, the guarantee balances were 105 million yuan and 240 million yuan respectively. As of the disclosure date of the announcement, the actual guarantee balance of the company and its holding subsidiaries was $345 million, accounting for 10.81% of the most recent audited net assets.

Guilin Sanjin announced that recently, the wholly-owned subsidiary Baochuan Biotech and Baifan Biotech applied to the Shanghai branch of Xiamen International Bank for an increase of 20 million yuan and 40 million yuan in credit lines, respectively, and the company provided guarantees for them. Before this guarantee, the company's guarantee balances for Baochuan Biotech and Baifan Biotech were 85 million yuan and 20 million yuan respectively; after this guarantee, the guarantee balances were 105 million yuan and 240 million yuan respectively. As of the disclosure date of the announcement, the actual guarantee balance of the company and its holding subsidiaries was $345 million, accounting for 10.81% of the most recent audited net assets.